相关实验视频
Updated: May 10, 2026

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
1.8K
在超重和肥胖成年人中命名的饮食计划中减肥的比较:一个元分析
Bradley C Johnston1, Steve Kanters2, Kristofer Bandayrel3
1Hospital for Sick Children Research Institute, Toronto, Ontario, Canada2Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hami.
JAMA
|September 4, 2014
概括
低碳水化合物和低脂肪饮食显著有助于减肥,特定的命名饮食之间差异很小. 建议患者遵守任何饮食是有效的体重管理的支持.
科学领域:
- 营养科学 营养科学
- 营养学 营养学 营养学
- 公共卫生 公共卫生
背景情况:
- 许多饮食声称在减肥方面优越,但比较其有效性的证据往往不清楚.
- 确定体重管理的最佳饮食方法在临床实践中仍然是一个重大挑战.
研究的目的:
- 为了评估各种流行的饮食中的减肥结果,按宏观营养素组成和特定的命名计划进行分类.
- 为超重和肥胖个体提供基于证据的饮食选择指南.
主要方法:
- 在2014年4月之前,对六个电子数据库进行了系统搜索.
- 包括涉及超重或肥胖成年人坚持命名饮食的随机试验.
- 贝叶斯网络元分析和元回归被用来比较饮食有效性,调整行为支持和运动.
主要成果:
- 低碳水化合物和低脂肪饮食在6个月和12个月的随访期间都显示出显著的体重减轻.
- 在个别命名的饮食之间减肥的差异被发现是最小的.
- 随着时间的推移,行为支持和运动对减肥结果的影响不同.
结论:
- 低碳水化合物和低脂肪饮食模式都有效实现显著的减肥.
- 选择特定的命名饮食似乎不像患者坚持那么重要.
- 临床建议应优先考虑个人可以始终遵循的饮食,以实现可持续的体重管理.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

